Abstract
Discrepancies between patient- and clinician-perceived cognitive functioning in people with schizophrenia have been associated with functional impairment, which can be further confounded by side effects of treatment. Perceived cognitive impairment and level of agreement between patient, clinician, and caregiver responses on the New York Assessment of Adverse Cognitive Effects of Neuropsychiatric Treatment (NY-AACENT) were assessed for patients with schizophrenia switching to the long-acting injectable antipsychotic aripiprazole lauroxil (AL).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
